DALLAS--(BUSINESS WIRE)--Colossal Biosciences (“Colossal”), the world’s first de-extinction company, announces today that their Woolly Mammoth team has achieved a global-first iPSC (induced ...

Scientists have made a leap in genetic engineering by pushing elephant cells into an embryonic-like state. This marks a major step toward recreating traits of the extinct woolly mammoth, offering new ...

My inbox started filling up with the supposedly groundbreaking news early Tuesday, breathless news articles about a ...

The start-up Colossal Biosciences aims to use gene-editing technology to bring back the woolly mammoth and other extinct species. Recently, the company achieved major milestones: last year, they ...

When the elevator doors part on the second floor of a two-story brick and glass building in an office park on the outskirts of downtown Dallas, it feels like a portal opening to a different world. The ...

Extinction is still forever, but scientists at the biotech company Colossal Biosciences are trying what they say is the next best thing to restoring ancient beasts — genetically engineering living ...

Forbes contributors publish independent expert analyses and insights. I write about biodiversity and the hidden quirks of the natural world. Colossal Biosciences is now valued at over $10 billion and ...

The Colossal Foundation, the nonprofit arm of the science fiction-y Dallas startup, announced Wednesday it had secured an additional $50 million in funding, bringing its total purse to $100 million.